Navigation Links
Genesis Biosciences Receives Pulire Innovation Award for e card Sanitary Bin Treatment Product
Date:6/16/2011

LAWRENCEVILLE, Ga. and CARDIFF, Wales, June 16, 2011 /PRNewswire/ -- Genesis Biosciences, a global leader in custom fermentation, microbial product formulation and antimicrobial product development, announced today that it received the Pulire Innovation Award in the chemical products category for its e card sanitary bin sanitizer. This prestigious award, which honors creative products, solutions and entrepreneurial ideas in the professional cleaning and environmental hygiene field, was presented to Genesis during the Pulire Exhibition in Verona last month. Genesis' e card is the latest addition to its Biosan series of products for treatment of sanitary waste.

(Logo:  http://photos.prnewswire.com/prnh/20110615/MM20879LOGO)

"As a first-time attendee of Pulire, our team is honored to be recognized by industry experts for our cutting-edge technology and innovative approach to the research and development instrumental in the creation of effective antimicrobial products for professional cleaning," stated Conrad Mielcuszny, president and chief executive officer of Genesis Biosciences. "At Genesis Biosciences, we are committed to constantly evolving and improving our technology to bring value to our customers, and this award represents the first of many accomplishments and achievements that our team expects to make this year."

The Pulire Exhibition, a globally respected industry event, is an international trade exhibition for professional cleaning technologies. The Pulire Innovation Award was open to the nearly 300 exhibitors participating in three categories: chemical products, machines and equipment. Three products for each nomination category were short-listed prior to the start of the trade show. These products, showcased by some of the top industry leaders, were characterized by progressive technologies and advanced know-how, and offered improved performance with regard to competitiveness, profitability, functionality, operator safety, reduced operating costs and times and environmental sustainability.

Genesis Biosciences was formed in 2009 when Biotal Technologies and Lawrenceville, Georgia-based Genesis Technologies were first acquired and then merged by the CKM Group. Genesis Biosciences is a market leader in bacteria fermentation and is the first company to develop, manufacture and offer both microbial and antimicrobial products. Based on the knowledge and experience of the company's scientists and lab technicians, the company utilizes its state-of-the-art in-house fermentation equipment and facilities to grow bacteria to the highest quality known in the marketplace. Additionally, Genesis creates solutions for the safe and natural eradication of bacteria using plant oils, essential oils and green chemistry.

About Genesis Biosciences

Genesis Biosciences is a biotechnology company specializing in bacteria fermentation, microbial, antimicrobial and environmentally preferred products and services. The company focuses its efforts on the development of diverse quality-assured products and solutions for a wide range of markets and applications. Genesis Biosciences emphasizes quality in every aspect of its business to ensure the most efficient, cost-effective solutions to meet customers' needs. Genesis Biosciences' U.S. facility is located in Lawrenceville, Georgia, and its European facility is in Cardiff, Wales. For more information, please visit www.genesisbiosciences.com.


'/>"/>
SOURCE Genesis Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharmas Scientific and Medical Advisory Board
2. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
3. ThermoGenesis Announces China Customer Implements Cord Blood Products
4. Tissue Genesis Begins FDA-Approved Clinical Trial
5. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
6. Organogenesis, Life Sciences Center Break Ground on Worlds Largest Automated Living Cell Manufacturing Plant
7. Announcing ValGenesis On-Demand SaaS Solution
8. Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
9. Genesis Biopharma Appoints William H. Andrews Ph.D. to Board of Directors
10. Genesis Biopharma Announces Plans to Develop Active Immunotherapy Platform
11. Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):